100
%
Arena Life Science Holding was established with the vision of creating a dynamic and sustainable ecosystem in the pharmaceutical and healthcare industry. Since its foundation, the holding has focused on innovation, investment, and strategic development, bringing together specialized companies and expert teams under one umbrella to deliver comprehensive solutions in life sciences.
HEALTH
FIRST ALWAYS
High-Quality Generics Focused on Cardiovascular, Diabetes, and acute Stroke Care.
Sales and marketing is a big part of Pharmaceuticals and Biotech drugs & recombinant medicines businesses.
At Arena Life Science, we deliver a range of high-quality generic medicines designed to address critical health needs, particularly in cardiovascular care, diabetes management, and acute stroke treatment. Our portfolio features innovative formulations such as Rivaroxaban (Axabin®), Apixaban (Apirax®), Ticagrelor (Ticalix®), Alteplase (Altelyse®) and more, all produced under strict quality standards.
OUR AREA OF EXPERTISE
Cardiovascular
Essential therapies for thrombosis prevention, acute events, hypertension, angina, and arrhythmia control.
Rheumatology
Targeted therapies for rheumatoid arthritis and inflammatory rheumatic diseases.
Neurology
Advanced solutions to manage epilepsy, chronic neuropathic pain, and central nervous system disorders.
Endocrinology
Essential treatments for diabetes management, thyroid conditions, and endocrine system disorders.
Contact
Links
Products
